ARCHIVES

NCI Offers Chlorozotocin

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

House Passes Bill On New Cigarette Labels

September 14, 1984

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Susan Weiner Named to HHS Panel

January 17, 2003

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009